Neuland Laboratories Ltd.
Research Neuland Laboratories Ltd. (NEULANDLAB.NS) on Bullrun: market cap INR 252.43B, P/E 50.7, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNEULANDLAB.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 252.43B
- P/E50.7
- Dividend yield0.2%
- Financial periodQ2 2026
- RevenueINR 6.42B
- Net incomeINR 1.48B
- Gross margin58.1%
Valuation Snapshot
latest market cap is INR 252.43B; P/E is 50.7; dividend yield is 0.2%.
Peer valuation comparison
Latest P/E is 50.71x versus a Healthcare sector median of 21.74x (133.2% above).
Latest dividend yield is 0.17% versus a Healthcare sector median of 2.4% (92.9% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 252.43B | 50.7 | 0.2% | 34 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 34 INR, yield 0.2%.
About Neuland Laboratories Ltd.
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Neuland Laboratories Ltd.'s market cap?
Neuland Laboratories Ltd.'s market capitalization is INR 252.43B.
What is Neuland Laboratories Ltd.'s P/E ratio?
Neuland Laboratories Ltd.'s price-to-earnings (P/E) ratio is 50.7.
Does Neuland Laboratories Ltd. pay a dividend?
Neuland Laboratories Ltd. has a dividend yield of 0.2%.
What does Neuland Laboratories Ltd. do?
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.